<?xml version="1.0" encoding="UTF-8"?>
<ref id="B153-pharmaceutics-12-00171">
 <label>153.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Balachandran</surname>
    <given-names>Y.L.</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Nan</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Amantadine Surface-Modified Silver Nanorods Improves Immunotherapy of HIV Vaccine Against HIV-Infected Cells</article-title>
  <source>ACS Appl. Mater. Interfaces</source>
  <year>2018</year>
  <volume>10</volume>
  <fpage>28494</fpage>
  <lpage>28501</lpage>
  <pub-id pub-id-type="doi">10.1021/acsami.8b10948</pub-id>
  <?supplied-pmid 30085647?>
  <pub-id pub-id-type="pmid">30085647</pub-id>
 </element-citation>
</ref>
